Opus Genetics, Inc. (NASDAQ:IRD) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
MarketBeat
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, f
NASDAQ:IRD